21 CFR 520.136
§ 520.136 Atinvicitinib tablets.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.136, § 520.136 Atinvicitinib tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87084
- Permanent ID
ys:prov:87084@1- SHA-256
da7a0d56be9bad5f707bf25b6f25978d26d297a0b3b3484080fdd30e4712eec9
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each tablet contains 4.8, 7.2, 21.6, or 31.6 milligrams (mg) of atinvicitinib.
(b) Sponsor. See No. 000061 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount. Administer 0.36 to 0.54 mg atinvicitinib per pound (0.8 to 1.2 mg atinvicitinib per kilogram) of body weight, once daily, with food.
(2) Indications for use. For the control of pruritus associated with allergic dermatitis in dogs 6 months of age and older.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.